Ryan J Bair1, Eric Bair2, Akila N Viswanathan3. 1. Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA. 2. Department of Endodontics, University of North Carolina, Chapel Hill, NC; Department of Biostatistics, University of North Carolina, Chapel Hill, NC. 3. Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA. Electronic address: aviswanathan@lroc.harvard.edu.
Abstract
PURPOSE: We assessed a novel Food and Drug Administration-approved hydrogel, synthesized as absorbable iodinated particles, in gynecologic-cancer patients undergoing computed tomography (CT) or magnetic resonance (MR) based brachytherapy after external beam radiation. METHODS AND MATERIALS: Nineteen patients underwent CT-guided (n = 13) or MR-guided (n = 6) brachytherapy for gynecologic cancers. Seventy-seven hydrogel injections were placed. The hydrogel material was injected into gross residual disease and/or key anatomic landmarks in amounts ranging from 0.1 to 0.4 mL. The visibility of the tracer was scored on CT and on MR images using a 5-point scoring scale. A Cohen's kappa statistic was calculated to assess interobserver agreement. To assess the unadjusted effects of baseline parameters on hydrogel visibility, we modeled visibility using a linear mixed-effect model. RESULTS: Injections were without complication. The kappa statistic was 0.77 (95% confidence interval [CI], 0.68-0.87). The volume of hydrogel injected was significantly associated with visibility on both CT (p = 0.032) and magnetic resonance imaging (p = 0.016). We analyzed visibility by location, controlling for amount. A 0.1-cc increase in volume injected was associated with increases of 0.54 (95% CI = 0.05-1.03) in the CT visibility score and 0.83 (95% CI = 0.17-1.49) in the MR visibility score. Injection of 0.4 cc or more was required for unequivocal visibility on CT or MR. No statistically significant correlation was found between tumor type, tumor location, or anatomical location of injection and visibility on either CT or magnetic resonance imaging. CONCLUSIONS: In this first report of an injectable radiopaque hydrogel, targets were visualized to assist with three-dimensional-based brachytherapy in gynecologic malignancies. This marker has potential for several applications, is easy to inject and visualize, and caused no acute complications.
PURPOSE: We assessed a novel Food and Drug Administration-approved hydrogel, synthesized as absorbable iodinated particles, in gynecologic-cancerpatients undergoing computed tomography (CT) or magnetic resonance (MR) based brachytherapy after external beam radiation. METHODS AND MATERIALS: Nineteen patients underwent CT-guided (n = 13) or MR-guided (n = 6) brachytherapy for gynecologic cancers. Seventy-seven hydrogel injections were placed. The hydrogel material was injected into gross residual disease and/or key anatomic landmarks in amounts ranging from 0.1 to 0.4 mL. The visibility of the tracer was scored on CT and on MR images using a 5-point scoring scale. A Cohen's kappa statistic was calculated to assess interobserver agreement. To assess the unadjusted effects of baseline parameters on hydrogel visibility, we modeled visibility using a linear mixed-effect model. RESULTS: Injections were without complication. The kappa statistic was 0.77 (95% confidence interval [CI], 0.68-0.87). The volume of hydrogel injected was significantly associated with visibility on both CT (p = 0.032) and magnetic resonance imaging (p = 0.016). We analyzed visibility by location, controlling for amount. A 0.1-cc increase in volume injected was associated with increases of 0.54 (95% CI = 0.05-1.03) in the CT visibility score and 0.83 (95% CI = 0.17-1.49) in the MR visibility score. Injection of 0.4 cc or more was required for unequivocal visibility on CT or MR. No statistically significant correlation was found between tumor type, tumor location, or anatomical location of injection and visibility on either CT or magnetic resonance imaging. CONCLUSIONS: In this first report of an injectable radiopaque hydrogel, targets were visualized to assist with three-dimensional-based brachytherapy in gynecologic malignancies. This marker has potential for several applications, is easy to inject and visualize, and caused no acute complications.
Authors: Neelam Tyagi; John H Lewis; Catheryn M Yashar; Daniel Vo; Steve B Jiang; Arno J Mundt; Loren K Mell Journal: Int J Radiat Oncol Biol Phys Date: 2010-11-23 Impact factor: 7.038
Authors: Nishita Kothary; Jeremy J Heit; John D Louie; William T Kuo; Billy W Loo; Albert Koong; Daniel T Chang; David Hovsepian; Daniel Y Sze; Lawrence V Hofmann Journal: J Vasc Interv Radiol Date: 2008-11-18 Impact factor: 3.464
Authors: Petra Georg; Stefan Lang; Johannes C A Dimopoulos; Wolfgang Dörr; Alina E Sturdza; Daniel Berger; Dietmar Georg; Christian Kirisits; Richard Pötter Journal: Int J Radiat Oncol Biol Phys Date: 2010-04-10 Impact factor: 7.038
Authors: Akila N Viswanathan; Jackie Szymonifka; Clare M Tempany-Afdhal; Desmond A O'Farrell; Robert A Cormack Journal: Brachytherapy Date: 2013-02-12 Impact factor: 2.362
Authors: Gencay Hatiboglu; Michael Pinkawa; Jean-Paul Vallée; Boris Hadaschik; Markus Hohenfellner Journal: BJU Int Date: 2012-07-12 Impact factor: 5.588
Authors: Avani D Rao; Ziwei Feng; Eun Ji Shin; Jin He; Kevin M Waters; Stephanie Coquia; Robert DeJong; Lauren M Rosati; Lin Su; Dengwang Li; Juan Jackson; Stephen Clark; Jeffrey Schultz; Danielle Hutchings; Seong-Hun Kim; Ralph H Hruban; Theodore L DeWeese; John Wong; Amol Narang; Joseph M Herman; Kai Ding Journal: Int J Radiat Oncol Biol Phys Date: 2017-08-14 Impact factor: 7.038
Authors: Avani D Rao; Eun Ji Shin; Sarah E Beck; Caroline Garrett; Seong-Hun Kim; Nam Ju Lee; Eleni Liapi; John Wong; Joseph Herman; Amol Narang; Kai Ding Journal: Int J Radiat Oncol Biol Phys Date: 2018-03-02 Impact factor: 7.038
Authors: Sarah O S Osman; Emily Russell; Raymond B King; Karen Crowther; Suneil Jain; Cormac McGrath; Alan R Hounsell; Kevin M Prise; Conor K McGarry Journal: Radiat Oncol Date: 2019-12-26 Impact factor: 3.481
Authors: Yazeed Alhiyari; Jundong Shao; Albert Y Han; Amanda Miller; Jeffrey F Krane; Marie Luff; Milica Momcilovic; David Shackelford; Zhen Gu; Maie A St John Journal: Sci Rep Date: 2022-03-04 Impact factor: 4.379